> top > docs > PMC:3342329 > spans > 9731-10504 > annotations

PMC:3342329 / 9731-10504 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T5412 748-752 Protein denotes CCR5
T5411 706-709 Protein denotes p50
T5410 594-598 Protein denotes CCR5
T5409 528-543 Phosphorylation denotes phosphorylation
T5408 514-524 Negative_regulation denotes inhibition
T5407 494-501 Entity denotes nucleus
T5406 481-484 Protein denotes p65
T5405 471-474 Protein denotes p50
T5404 454-467 Localization denotes translocation
T5403 401-405 Protein denotes CCR5
T5402 111-115 Protein denotes CCR5
T5400 748-752 Protein denotes CCR5
T5399 706-709 Protein denotes p50
T5398 594-598 Protein denotes CCR5
T5397 481-484 Protein denotes p65
T5396 471-474 Protein denotes p50
T5395 401-405 Protein denotes CCR5
T5394 111-115 Protein denotes CCR5
R3680 T5405 T5404 themeOf p50,translocation
R3681 T5406 T5404 themeOf p65,translocation
R3682 T5407 T5404 locationOf nucleus,translocation
R3683 T5409 T5408 themeOf phosphorylation,inhibition

testone

Id Subject Object Predicate Lexical cue
T5392 528-543 Phosphorylation denotes phosphorylation
T5391 494-501 Entity denotes nucleus
T5390 454-467 Localization denotes translocation
T5389 116-126 Gene_expression denotes expression
T5388 748-752 Protein denotes CCR5
T5387 706-709 Protein denotes p50
T5386 594-598 Protein denotes CCR5
T5385 481-484 Protein denotes p65
T5384 471-474 Protein denotes p50
T5383 401-405 Protein denotes CCR5
T5382 111-115 Protein denotes CCR5
R3676 T5382 T5389 themeOf CCR5,expression
R3677 T5384 T5390 themeOf p50,translocation
R3678 T5385 T5390 themeOf p65,translocation
R3679 T5391 T5390 locationOf nucleus,translocation

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T5833 714-723 Negative_regulation denotes decreased
T5832 560-569 Negative_regulation denotes prevented
T5831 454-467 Localization denotes translocation
T5830 116-126 Gene_expression denotes expression
T5829 748-752 Protein denotes CCR5
T5828 706-709 Protein denotes p50
T5827 594-598 Protein denotes CCR5
T5826 481-484 Protein denotes p65
T5825 471-474 Protein denotes p50
T5824 401-405 Protein denotes CCR5
T5823 111-115 Protein denotes CCR5
R4012 T5823 T5830 themeOf CCR5,expression
R4013 T5825 T5831 themeOf p50,translocation
R4014 T5826 T5831 themeOf p65,translocation
R4015 T5828 T5833 themeOf p50,decreased
R4016 T5831 T5832 themeOf translocation,prevented
R4017 T5831 T5832 themeOf translocation,prevented

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T5635 693-701 Localization denotes staining
T5634 714-723 Negative_regulation denotes decreased
T5633 454-467 Localization denotes translocation
T5632 528-543 Phosphorylation denotes phosphorylation
T5631 514-524 Negative_regulation denotes inhibition
T5630 560-569 Negative_regulation denotes prevented
T5629 116-126 Gene_expression denotes expression
T5628 748-752 Protein denotes CCR5
T5627 706-709 Protein denotes p50
T5626 594-598 Protein denotes CCR5
T5625 481-484 Protein denotes p65
T5624 471-474 Protein denotes p50
T5623 401-405 Protein denotes CCR5
T5622 111-115 Protein denotes CCR5
R3836 T5622 T5629 themeOf CCR5,expression
R3837 T5624 T5632 themeOf p50,phosphorylation
R3838 T5624 T5633 themeOf p50,translocation
R3839 T5625 T5633 themeOf p65,translocation
R3840 T5627 T5635 themeOf p50,staining
R3841 T5627 T5634 themeOf p50,decreased
R3842 T5632 T5631 themeOf phosphorylation,inhibition
R3843 T5633 T5630 themeOf translocation,prevented
R3844 T5633 T5630 themeOf translocation,prevented

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T5620 771-772 -RRB- denotes )
T5619 769-771 NN denotes 2C
T5618 762-768 NN denotes Figure
T5617 761-762 -LRB- denotes (
T5616 756-760 NN denotes mice
T5615 748-755 NN denotes CCR5−/−
T5614 745-747 IN denotes of
T5613 737-744 NN denotes tissues
T5612 731-736 NN denotes tumor
T5611 727-730 DT denotes the
T5610 724-726 IN denotes in
T5609 714-723 VB denotes decreased
T5608 710-713 VB denotes had
T5607 706-709 NN denotes p50
T5606 702-705 IN denotes for
T5605 693-701 NN denotes staining
T5604 685-692 JJ denotes nuclear
T5603 682-684 IN denotes of
T5602 672-681 NN denotes intensity
T5601 668-671 DT denotes the
T5600 663-667 IN denotes that
T5599 653-662 VB denotes confirmed
T5598 648-652 RB denotes also
T5597 639-647 NN denotes analysis
T5596 620-638 NN denotes Immunofluorescence
T5595 617-618 -RRB- denotes )
T5594 615-617 NN denotes 2B
T5593 608-614 NN denotes Figure
T5592 607-608 -LRB- denotes (
T5591 602-606 NN denotes mice
T5590 594-601 NN denotes CCR5−/−
T5589 591-593 IN denotes of
T5588 583-590 NN denotes tissues
T5587 577-582 NN denotes tumor
T5586 573-576 DT denotes the
T5585 570-572 IN denotes in
T5584 560-569 VB denotes prevented
T5583 555-559 RB denotes also
T5582 551-554 VB denotes was
T5581 547-550 NN denotes IκB
T5580 544-546 IN denotes of
T5579 528-543 NN denotes phosphorylation
T5578 525-527 IN denotes of
T5577 514-524 NN denotes inhibition
T5576 510-513 DT denotes the
T5575 502-509 IN denotes through
T5574 494-501 NN denotes nucleus
T5573 490-493 DT denotes the
T5572 485-489 IN denotes into
T5571 479-484 NN denotes p-p65
T5570 475-478 CC denotes and
T5569 471-474 NN denotes p50
T5568 468-470 IN denotes of
T5567 454-467 NN denotes translocation
T5566 450-453 DT denotes the
T5565 448-449 -COMMA- denotes ,
T5564 440-448 RB denotes Moreover
T5563 437-438 -RRB- denotes )
T5562 435-437 NN denotes 2A
T5561 428-434 NN denotes Figure
T5560 427-428 -LRB- denotes (
T5559 420-426 NN denotes tissue
T5558 414-419 NN denotes tumor
T5557 409-413 NN denotes mice
T5556 401-408 NN denotes CCR5−/−
T5555 397-400 DT denotes the
T5554 394-396 IN denotes in
T5553 386-393 VB denotes reduced
T5552 382-385 VB denotes was
T5551 373-381 NN denotes activity
T5550 365-372 NN denotes binding
T5549 361-364 NN denotes DNA
T5548 351-360 VB denotes activated
T5547 336-350 RB denotes constitutively
T5546 332-335 DT denotes The
T5545 324-330 NN denotes tissue
T5544 315-323 NN denotes melanoma
T5543 312-314 IN denotes in
T5542 310-311 -RRB- denotes )
T5541 306-310 NN denotes EMSA
T5540 305-306 -LRB- denotes (
T5539 299-304 NN denotes assay
T5538 293-298 NN denotes shift
T5537 277-292 NN denotes electromobility
T5536 274-276 IN denotes by
T5535 263-273 VB denotes determined
T5534 259-262 VB denotes was
T5533 253-258 NN denotes NF-κB
T5532 250-252 IN denotes of
T5531 241-249 NN denotes activity
T5530 233-240 NN denotes binding
T5529 229-232 NN denotes DNA
T5528 225-228 DT denotes the
T5527 223-224 -COMMA- denotes ,
T5526 215-223 NN denotes melanoma
T5525 212-214 IN denotes in
T5524 206-211 NN denotes NF-κB
T5523 203-205 IN denotes of
T5522 190-202 NN denotes inactivation
T5521 186-189 DT denotes the
T5520 181-185 IN denotes with
T5519 173-180 VB denotes related
T5518 169-172 VB denotes was
T5517 158-168 NN denotes inhibition
T5516 152-157 NN denotes tumor
T5515 148-151 DT denotes the
T5514 140-147 IN denotes whether
T5513 131-139 VB denotes evaluate
T5512 128-130 TO denotes To
T5511 116-126 NN denotes expression
T5510 111-115 NN denotes CCR5
T5509 108-110 IN denotes in
T5508 104-107 CC denotes and
T5507 98-103 NN denotes cells
T5506 91-97 NN denotes cancer
T5505 82-90 NN denotes melanoma
T5504 71-81 RB denotes especially
T5503 69-70 -COMMA- denotes ,
T5502 61-69 NN denotes survival
T5501 56-60 NN denotes cell
T5500 49-55 NN denotes cancer
T5499 46-48 IN denotes in
T5498 41-45 NN denotes role
T5497 32-40 JJ denotes critical
T5496 30-31 DT denotes a
T5495 24-29 VB denotes plays
T5494 18-23 NN denotes NF-κB
T5493 15-17 IN denotes of
T5492 4-14 NN denotes activation
T5491 0-3 DT denotes The
R3705 T5492 T5491 arg1Of activation,The
R3706 T5492 T5493 arg1Of activation,of
R3707 T5492 T5495 arg1Of activation,plays
R3708 T5494 T5493 arg2Of NF-κB,of
R3709 T5495 T5499 arg1Of plays,in
R3710 T5495 T5509 arg1Of plays,in
R3711 T5498 T5495 arg2Of role,plays
R3712 T5498 T5496 arg1Of role,a
R3713 T5498 T5497 arg1Of role,critical
R3714 T5499 T5508 arg1Of in,and
R3715 T5502 T5500 arg1Of survival,cancer
R3716 T5502 T5501 arg1Of survival,cell
R3717 T5502 T5503 arg1Of survival,","
R3718 T5503 T5499 arg2Of ",",in
R3719 T5507 T5503 arg2Of cells,","
R3720 T5507 T5504 arg1Of cells,especially
R3721 T5507 T5505 arg1Of cells,melanoma
R3722 T5507 T5506 arg1Of cells,cancer
R3723 T5509 T5508 arg2Of in,and
R3724 T5511 T5509 arg2Of expression,in
R3725 T5511 T5510 arg1Of expression,CCR5
R3726 T5513 T5512 arg1Of evaluate,To
R3727 T5517 T5515 arg1Of inhibition,the
R3728 T5517 T5516 arg1Of inhibition,tumor
R3729 T5517 T5518 arg1Of inhibition,was
R3730 T5517 T5519 arg2Of inhibition,related
R3731 T5519 T5513 arg2Of related,evaluate
R3732 T5519 T5514 arg1Of related,whether
R3733 T5519 T5518 arg2Of related,was
R3734 T5519 T5520 arg1Of related,with
R3735 T5522 T5520 arg2Of inactivation,with
R3736 T5522 T5521 arg1Of inactivation,the
R3737 T5522 T5523 arg1Of inactivation,of
R3738 T5522 T5525 arg1Of inactivation,in
R3739 T5524 T5523 arg2Of NF-κB,of
R3740 T5526 T5525 arg2Of melanoma,in
R3741 T5531 T5528 arg1Of activity,the
R3742 T5531 T5529 arg1Of activity,DNA
R3743 T5531 T5530 arg1Of activity,binding
R3744 T5531 T5532 arg1Of activity,of
R3745 T5531 T5534 arg1Of activity,was
R3746 T5531 T5535 arg2Of activity,determined
R3747 T5533 T5532 arg2Of NF-κB,of
R3748 T5535 T5512 modOf determined,To
R3749 T5535 T5527 arg1Of determined,","
R3750 T5535 T5534 arg2Of determined,was
R3751 T5539 T5535 arg1Of assay,determined
R3752 T5539 T5536 arg2Of assay,by
R3753 T5539 T5537 arg1Of assay,electromobility
R3754 T5539 T5538 arg1Of assay,shift
R3755 T5539 T5540 arg1Of assay,(
R3756 T5539 T5543 arg1Of assay,in
R3757 T5541 T5540 arg2Of EMSA,(
R3758 T5542 T5540 arg3Of ),(
R3759 T5545 T5543 arg2Of tissue,in
R3760 T5545 T5544 arg1Of tissue,melanoma
R3761 T5548 T5547 arg1Of activated,constitutively
R3762 T5551 T5546 arg1Of activity,The
R3763 T5551 T5548 arg1Of activity,activated
R3764 T5551 T5549 arg1Of activity,DNA
R3765 T5551 T5550 arg1Of activity,binding
R3766 T5551 T5552 arg1Of activity,was
R3767 T5551 T5553 arg2Of activity,reduced
R3768 T5553 T5552 arg2Of reduced,was
R3769 T5553 T5554 arg1Of reduced,in
R3770 T5559 T5554 arg2Of tissue,in
R3771 T5559 T5555 arg1Of tissue,the
R3772 T5559 T5556 arg1Of tissue,CCR5−/−
R3773 T5559 T5557 arg1Of tissue,mice
R3774 T5559 T5558 arg1Of tissue,tumor
R3775 T5559 T5560 arg1Of tissue,(
R3776 T5562 T5560 arg2Of 2A,(
R3777 T5562 T5561 arg1Of 2A,Figure
R3778 T5563 T5560 arg3Of ),(
R3779 T5567 T5566 arg1Of translocation,the
R3780 T5567 T5568 arg1Of translocation,of
R3781 T5567 T5582 arg1Of translocation,was
R3782 T5567 T5584 arg2Of translocation,prevented
R3783 T5569 T5570 arg1Of p50,and
R3784 T5570 T5568 arg2Of and,of
R3785 T5570 T5572 arg1Of and,into
R3786 T5570 T5575 arg1Of and,through
R3787 T5571 T5570 arg2Of p-p65,and
R3788 T5574 T5572 arg2Of nucleus,into
R3789 T5574 T5573 arg1Of nucleus,the
R3790 T5577 T5575 arg2Of inhibition,through
R3791 T5577 T5576 arg1Of inhibition,the
R3792 T5577 T5578 arg1Of inhibition,of
R3793 T5579 T5578 arg2Of phosphorylation,of
R3794 T5579 T5580 arg1Of phosphorylation,of
R3795 T5581 T5580 arg2Of IκB,of
R3796 T5584 T5564 arg1Of prevented,Moreover
R3797 T5584 T5565 arg1Of prevented,","
R3798 T5584 T5582 arg2Of prevented,was
R3799 T5584 T5583 arg1Of prevented,also
R3800 T5584 T5585 arg1Of prevented,in
R3801 T5588 T5585 arg2Of tissues,in
R3802 T5588 T5586 arg1Of tissues,the
R3803 T5588 T5587 arg1Of tissues,tumor
R3804 T5588 T5589 arg1Of tissues,of
R3805 T5591 T5589 arg2Of mice,of
R3806 T5591 T5590 arg1Of mice,CCR5−/−
R3807 T5591 T5592 arg1Of mice,(
R3808 T5594 T5592 arg2Of 2B,(
R3809 T5594 T5593 arg1Of 2B,Figure
R3810 T5595 T5592 arg3Of ),(
R3811 T5597 T5596 arg1Of analysis,Immunofluorescence
R3812 T5597 T5599 arg1Of analysis,confirmed
R3813 T5599 T5598 arg1Of confirmed,also
R3814 T5602 T5601 arg1Of intensity,the
R3815 T5602 T5603 arg1Of intensity,of
R3816 T5602 T5606 arg1Of intensity,for
R3817 T5602 T5608 arg1Of intensity,had
R3818 T5602 T5609 arg1Of intensity,decreased
R3819 T5605 T5603 arg2Of staining,of
R3820 T5605 T5604 arg1Of staining,nuclear
R3821 T5607 T5606 arg2Of p50,for
R3822 T5609 T5599 arg2Of decreased,confirmed
R3823 T5609 T5600 arg1Of decreased,that
R3824 T5609 T5608 arg2Of decreased,had
R3825 T5609 T5610 arg1Of decreased,in
R3826 T5613 T5610 arg2Of tissues,in
R3827 T5613 T5611 arg1Of tissues,the
R3828 T5613 T5612 arg1Of tissues,tumor
R3829 T5613 T5614 arg1Of tissues,of
R3830 T5616 T5614 arg2Of mice,of
R3831 T5616 T5615 arg1Of mice,CCR5−/−
R3832 T5616 T5617 arg1Of mice,(
R3833 T5619 T5617 arg2Of 2C,(
R3834 T5619 T5618 arg1Of 2C,Figure
R3835 T5620 T5617 arg3Of ),(

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T5450 748-752 Protein denotes CCR5
T5449 706-709 Protein denotes p50
T5448 594-598 Protein denotes CCR5
T5447 481-484 Protein denotes p65
T5446 471-474 Protein denotes p50
T5445 401-405 Protein denotes CCR5
T5444 111-115 Protein denotes CCR5

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T5799 706-709 http://www.uniprot.org/uniprot/P19838 denotes p50
T5798 471-474 http://www.uniprot.org/uniprot/P19838 denotes p50
T5797 748-752 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T5796 594-598 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T5795 401-405 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T5794 111-115 http://www.uniprot.org/uniprot/P51681 denotes CCR5

UBERON-AE

Id Subject Object Predicate Lexical cue
T5417 737-744 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues
T5416 583-590 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues
T5415 420-426 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue
T5414 324-330 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue

GO-BP

Id Subject Object Predicate Lexical cue
T5457 528-550 http://purl.obolibrary.org/obo/GO_0007252 denotes phosphorylation of IκB
T5456 528-543 http://purl.obolibrary.org/obo/GO_0016310 denotes phosphorylation
T5455 514-550 http://purl.obolibrary.org/obo/GO_1903720 denotes inhibition of phosphorylation of IκB
T5454 514-543 http://purl.obolibrary.org/obo/GO_0042326 denotes inhibition of phosphorylation
T5453 351-372 http://purl.obolibrary.org/obo/GO_1904744 denotes activated DNA binding
T5452 351-372 http://purl.obolibrary.org/obo/GO_0043388 denotes activated DNA binding
T5451 4-23 http://purl.obolibrary.org/obo/GO_0051092 denotes activation of NF-κB

GO-MF

Id Subject Object Predicate Lexical cue
T5464 365-372 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T5463 233-240 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T5462 361-372 http://purl.obolibrary.org/obo/GO_0003677 denotes DNA binding
T5461 229-240 http://purl.obolibrary.org/obo/GO_0003677 denotes DNA binding

GO-CC

Id Subject Object Predicate Lexical cue
T5460 494-501 http://purl.obolibrary.org/obo/GO_0005634 denotes nucleus
T5459 98-103 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T5458 56-60 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

sentences

Id Subject Object Predicate Lexical cue
T5423 620-773 Sentence denotes Immunofluorescence analysis also confirmed that the intensity of nuclear staining for p50 had decreased in the tumor tissues of CCR5−/− mice (Figure 2C).
T5422 440-619 Sentence denotes Moreover, the translocation of p50 and p-p65 into the nucleus through the inhibition of phosphorylation of IκB was also prevented in the tumor tissues of CCR5−/− mice (Figure 2B).
T5421 332-439 Sentence denotes The constitutively activated DNA binding activity was reduced in the CCR5−/− mice tumor tissue (Figure 2A).
T5420 128-331 Sentence denotes To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activity of NF-κB was determined by electromobility shift assay (EMSA) in melanoma tissue.
T5419 0-127 Sentence denotes The activation of NF-κB plays a critical role in cancer cell survival, especially melanoma cancer cells and in CCR5 expression.
T77 0-127 Sentence denotes The activation of NF-κB plays a critical role in cancer cell survival, especially melanoma cancer cells and in CCR5 expression.
T78 128-331 Sentence denotes To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activity of NF-κB was determined by electromobility shift assay (EMSA) in melanoma tissue.
T79 332-439 Sentence denotes The constitutively activated DNA binding activity was reduced in the CCR5−/− mice tumor tissue (Figure 2A).
T80 440-619 Sentence denotes Moreover, the translocation of p50 and p-p65 into the nucleus through the inhibition of phosphorylation of IκB was also prevented in the tumor tissues of CCR5−/− mice (Figure 2B).
T81 620-773 Sentence denotes Immunofluorescence analysis also confirmed that the intensity of nuclear staining for p50 had decreased in the tumor tissues of CCR5−/− mice (Figure 2C).

simple1

Id Subject Object Predicate Lexical cue
T5480 748-752 Protein denotes CCR5
T5479 706-709 Protein denotes p50
T5478 594-598 Protein denotes CCR5
T5477 481-484 Protein denotes p65
T5476 471-474 Protein denotes p50
T5475 401-405 Protein denotes CCR5
T5474 111-115 Protein denotes CCR5

DLUT931

Id Subject Object Predicate Lexical cue
T5811 560-569 Negative_regulation denotes prevented
T5810 514-524 Negative_regulation denotes inhibition
T5809 454-467 Localization denotes translocation
T5808 116-126 Gene_expression denotes expression
T5807 748-752 Protein denotes CCR5
T5806 706-709 Protein denotes p50
T5805 594-598 Protein denotes CCR5
T5804 481-484 Protein denotes p65
T5803 471-474 Protein denotes p50
T5802 401-405 Protein denotes CCR5
T5801 111-115 Protein denotes CCR5
R4002 T5801 T5808 themeOf CCR5,expression
R4003 T5803 T5809 themeOf p50,translocation
R4004 T5804 T5809 themeOf p65,translocation
R4005 T5809 T5810 themeOf translocation,inhibition
R4006 T5809 T5811 themeOf translocation,prevented
R4007 T5809 T5810 themeOf translocation,inhibition
R4008 T5809 T5811 themeOf translocation,prevented

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T5903 186-223 Negative_regulation denotes the inactivation of NF-κB in melanoma
T5901 450-590 Negative_regulation denotes the translocation of p50 and p-p65 into the nucleus through the inhibition of phosphorylation of IκB was also prevented in the tumor tissues
T5900 111-126 Gene_expression denotes CCR5 expression
T5899 0-23 Positive_regulation denotes The activation of NF-κB
T5898 471-474 Protein denotes p50
T5897 203-211 Protein denotes of NF-κB
T5896 49-70 Entity denotes cancer cell survival,
T5895 706-709 Protein denotes p50
T5894 602-618 Protein denotes mice (Figure 2B)
T5892 15-23 Protein denotes of NF-κB
T5891 490-501 Entity denotes the nucleus
T5890 250-258 Protein denotes of NF-κB
T5889 479-484 Protein denotes p-p65
T5888 756-772 Protein denotes mice (Figure 2C)
T5887 111-115 Protein denotes CCR5
T5886 409-413 Protein denotes mice
T5885 82-103 Entity denotes melanoma cancer cells
R4050 T5887 T5900 themeOf CCR5,CCR5 expression
R4051 T5892 T5899 themeOf of NF-κB,The activation of NF-κB
R4053 T5897 T5903 themeOf of NF-κB,the inactivation of NF-κB in melanoma

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T17919 126-127 . denotes .
T5792 772-773 . denotes .
T5791 771-772 -RRB- denotes )
T5790 769-771 CD denotes 2C
T5789 762-768 NN denotes Figure
T5788 761-762 -LRB- denotes (
T5787 756-760 NNS denotes mice
T5786 754-755 NN denotes −
T5781 737-744 NNS denotes tissues
T5780 731-736 NN denotes tumor
T5779 727-730 DT denotes the
T5778 724-726 IN denotes in
T5777 714-723 VBN denotes decreased
T5776 710-713 VBD denotes had
T5775 706-709 CD denotes p50
T5774 702-705 IN denotes for
T5773 693-701 NN denotes staining
T5772 685-692 JJ denotes nuclear
T5771 682-684 IN denotes of
T5770 672-681 NN denotes intensity
T5769 668-671 DT denotes the
T5768 663-667 IN denotes that
T5767 653-662 VBD denotes confirmed
T5766 648-652 RB denotes also
T5765 639-647 NN denotes analysis
T5764 620-638 NNP denotes Immunofluorescence
T5763 618-619 . denotes .
T5762 617-618 -RRB- denotes )
T5761 615-617 NN denotes 2B
T5760 608-614 NN denotes Figure
T5759 607-608 -LRB- denotes (
T5758 602-606 NNS denotes mice
T5757 600-601 NN denotes −
T5756 599-600 NN denotes /
T5755 598-599 CD denotes −
T5754 594-598 CD denotes CCR5
T5753 591-593 IN denotes of
T5752 583-590 NNS denotes tissues
T5751 577-582 NN denotes tumor
T5750 573-576 DT denotes the
T5749 570-572 IN denotes in
T5748 560-569 VBN denotes prevented
T5747 555-559 RB denotes also
T5746 551-554 VBD denotes was
T5745 547-550 NNP denotes IκB
T5744 544-546 IN denotes of
T5743 528-543 NN denotes phosphorylation
T5742 525-527 IN denotes of
T5741 514-524 NN denotes inhibition
T5740 510-513 DT denotes the
T5739 502-509 IN denotes through
T5738 494-501 NN denotes nucleus
T5737 490-493 DT denotes the
T5736 485-489 IN denotes into
T5735 479-484 CD denotes p-p65
T5734 475-478 CC denotes and
T5733 471-474 CD denotes p50
T5732 468-470 IN denotes of
T5731 454-467 NN denotes translocation
T5730 450-453 DT denotes the
T5729 448-449 , denotes ,
T5728 440-448 RB denotes Moreover
T5727 438-439 . denotes .
T5726 437-438 -RRB- denotes )
T5725 435-437 NN denotes 2A
T5724 428-434 NN denotes Figure
T5723 427-428 -LRB- denotes (
T5722 420-426 NN denotes tissue
T5721 414-419 NN denotes tumor
T5720 409-413 NNS denotes mice
T5719 407-408 CD denotes −
T5718 406-407 VBD denotes /
T5717 405-406 NNP denotes −
T5716 401-405 NNP denotes CCR5
T5715 397-400 DT denotes the
T5714 394-396 IN denotes in
T5713 386-393 VBN denotes reduced
T5712 382-385 VBD denotes was
T5711 373-381 NN denotes activity
T5710 365-372 JJ denotes binding
T5709 361-364 NNP denotes DNA
T5708 351-360 VBN denotes activated
T5707 336-350 RB denotes constitutively
T5706 332-335 DT denotes The
T5705 330-331 . denotes .
T5704 324-330 NN denotes tissue
T5703 315-323 NN denotes melanoma
T5702 312-314 IN denotes in
T5701 310-311 -RRB- denotes )
T5700 306-310 NNP denotes EMSA
T5699 305-306 -LRB- denotes (
T5698 299-304 NN denotes assay
T5697 293-298 NN denotes shift
T5696 277-292 NN denotes electromobility
T5695 274-276 IN denotes by
T5694 263-273 VBN denotes determined
T5693 259-262 VBD denotes was
T5692 253-258 NN denotes NF-κB
T5691 250-252 IN denotes of
T5690 241-249 NN denotes activity
T5689 233-240 JJ denotes binding
T5688 229-232 NNP denotes DNA
T5687 225-228 DT denotes the
T5686 223-224 , denotes ,
T5685 215-223 NN denotes melanoma
T5684 212-214 IN denotes in
T5683 206-211 NN denotes NF-κB
T5682 203-205 IN denotes of
T5681 190-202 NN denotes inactivation
T5680 186-189 DT denotes the
T5679 181-185 IN denotes with
T5678 173-180 VBN denotes related
T5677 169-172 VBD denotes was
T5676 158-168 NN denotes inhibition
T5675 152-157 NN denotes tumor
T5674 148-151 DT denotes the
T5673 140-147 IN denotes whether
T5672 131-139 VB denotes evaluate
T5671 128-130 TO denotes To
T5670 126-127 . denotes .
T5669 116-126 NN denotes expression
T5668 111-115 CD denotes CCR5
T5667 108-110 IN denotes in
T5666 104-107 CC denotes and
T5665 98-103 NNS denotes cells
T5664 91-97 NN denotes cancer
T5663 82-90 NN denotes melanoma
T5662 71-81 RB denotes especially
T5661 69-70 , denotes ,
T5660 61-69 NN denotes survival
T5659 56-60 NN denotes cell
T5658 49-55 NN denotes cancer
T5657 46-48 IN denotes in
T5656 41-45 NN denotes role
T5655 32-40 JJ denotes critical
T5654 30-31 DT denotes a
T5653 24-29 NNS denotes plays
T5652 18-23 JJ denotes NF-κB
T5651 15-17 IN denotes of
T5650 4-14 NN denotes activation
T5649 0-3 DT denotes The
T5785 753-754 NN denotes /
T5784 752-753 CD denotes −
T5783 748-752 CD denotes CCR5
T5782 745-747 IN denotes of
R3858 T5649 T5650 det The,activation
R3859 T5650 T5650 ROOT activation,activation
R3860 T5651 T5650 prep of,activation
R3861 T5652 T5653 amod NF-κB,plays
R3862 T5653 T5651 pobj plays,of
R3863 T5654 T5656 det a,role
R3864 T5655 T5656 amod critical,role
R3865 T5656 T5650 conj role,activation
R3866 T5657 T5656 prep in,role
R3867 T5658 T5659 compound cancer,cell
R3868 T5659 T5660 compound cell,survival
R3869 T5660 T5657 pobj survival,in
R3870 T5661 T5657 punct ",",in
R3871 T5662 T5665 advmod especially,cells
R3872 T5663 T5665 compound melanoma,cells
R3873 T5664 T5665 compound cancer,cells
R3874 T5665 T5656 appos cells,role
R3875 T5666 T5650 cc and,activation
R3876 T5667 T5650 prep in,activation
R3877 T5668 T5669 amod CCR5,expression
R3878 T5669 T5667 pobj expression,in
R3879 T5670 T5650 punct .,activation
R3880 T5671 T5672 aux To,evaluate
R3881 T5672 T5694 advcl evaluate,determined
R3882 T5673 T5678 mark whether,related
R3883 T5674 T5676 det the,inhibition
R3884 T5675 T5676 compound tumor,inhibition
R3885 T5676 T5678 nsubjpass inhibition,related
R3886 T5677 T5678 auxpass was,related
R3887 T5678 T5672 advcl related,evaluate
R3888 T5679 T5678 prep with,related
R3889 T5680 T5681 det the,inactivation
R3890 T5681 T5679 pobj inactivation,with
R3891 T5682 T5681 prep of,inactivation
R3892 T5683 T5682 pobj NF-κB,of
R3893 T5684 T5681 prep in,inactivation
R3894 T5685 T5684 pobj melanoma,in
R3895 T5686 T5681 punct ",",inactivation
R3896 T5687 T5690 det the,activity
R3897 T5688 T5690 compound DNA,activity
R3898 T5689 T5690 amod binding,activity
R3899 T5690 T5681 conj activity,inactivation
R3900 T5691 T5690 prep of,activity
R3901 T5692 T5691 pobj NF-κB,of
R3902 T5693 T5694 auxpass was,determined
R3903 T5694 T5694 ROOT determined,determined
R3904 T5695 T5694 agent by,determined
R3905 T5696 T5698 compound electromobility,assay
R3906 T5697 T5698 compound shift,assay
R3907 T5698 T5695 pobj assay,by
R3908 T5699 T5698 punct (,assay
R3909 T5700 T5698 appos EMSA,assay
R3910 T5701 T5698 punct ),assay
R3911 T5702 T5694 prep in,determined
R3912 T5703 T5704 compound melanoma,tissue
R3913 T5704 T5702 pobj tissue,in
R3914 T5705 T5694 punct .,determined
R3915 T5706 T5711 det The,activity
R3916 T5707 T5708 advmod constitutively,activated
R3917 T5708 T5711 amod activated,activity
R3918 T5709 T5711 amod DNA,activity
R3919 T5710 T5711 amod binding,activity
R3920 T5711 T5713 nsubjpass activity,reduced
R3921 T5712 T5713 auxpass was,reduced
R3922 T5713 T5713 ROOT reduced,reduced
R3923 T5714 T5713 prep in,reduced
R3924 T5715 T5717 det the,−
R3925 T5716 T5717 compound CCR5,−
R3926 T5717 T5714 pobj −,in
R3927 T5718 T5713 advcl /,reduced
R3928 T5719 T5720 nummod −,mice
R3929 T5720 T5725 compound mice,2A
R3930 T5721 T5722 compound tumor,tissue
R3931 T5722 T5725 compound tissue,2A
R3932 T5723 T5724 punct (,Figure
R3933 T5724 T5725 compound Figure,2A
R3934 T5725 T5718 dobj 2A,/
R3935 T5726 T5713 punct ),reduced
R3936 T5727 T5713 punct .,reduced
R3937 T5728 T5748 advmod Moreover,prevented
R3938 T5729 T5748 punct ",",prevented
R3939 T5730 T5731 det the,translocation
R3940 T5731 T5748 nsubjpass translocation,prevented
R3941 T5732 T5731 prep of,translocation
R3942 T5733 T5732 pobj p50,of
R3943 T5734 T5733 cc and,p50
R3944 T5735 T5733 conj p-p65,p50
R3945 T5736 T5731 prep into,translocation
R3946 T5737 T5738 det the,nucleus
R3947 T5738 T5736 pobj nucleus,into
R3948 T5739 T5731 prep through,translocation
R3949 T5740 T5741 det the,inhibition
R3950 T5741 T5739 pobj inhibition,through
R3951 T5742 T5741 prep of,inhibition
R3952 T5743 T5742 pobj phosphorylation,of
R3953 T5744 T5743 prep of,phosphorylation
R3954 T5745 T5744 pobj IκB,of
R3955 T5746 T5748 auxpass was,prevented
R3956 T5747 T5748 advmod also,prevented
R3957 T5748 T5748 ROOT prevented,prevented
R3958 T5749 T5748 prep in,prevented
R3959 T5750 T5752 det the,tissues
R3960 T5751 T5752 compound tumor,tissues
R3961 T5752 T5749 pobj tissues,in
R3962 T5753 T5752 prep of,tissues
R3963 T5754 T5758 nummod CCR5,mice
R3964 T5755 T5758 nummod −,mice
R3965 T5756 T5758 nmod /,mice
R3966 T5757 T5758 compound −,mice
R3967 T5758 T5753 pobj mice,of
R3968 T5759 T5761 punct (,2B
R3969 T5760 T5761 compound Figure,2B
R3970 T5761 T5758 appos 2B,mice
R3971 T5762 T5748 punct ),prevented
R3972 T5763 T5748 punct .,prevented
R3973 T5764 T5765 compound Immunofluorescence,analysis
R3974 T5765 T5767 nsubj analysis,confirmed
R3975 T5766 T5767 advmod also,confirmed
R3976 T5767 T5767 ROOT confirmed,confirmed
R3977 T5768 T5777 mark that,decreased
R3978 T5769 T5770 det the,intensity
R3979 T5770 T5777 nsubj intensity,decreased
R3980 T5771 T5770 prep of,intensity
R3981 T5772 T5773 amod nuclear,staining
R3982 T5773 T5771 pobj staining,of
R3983 T5774 T5770 prep for,intensity
R3984 T5775 T5774 pobj p50,for
R3985 T5776 T5777 aux had,decreased
R3986 T5777 T5767 ccomp decreased,confirmed
R3987 T5778 T5777 prep in,decreased
R3988 T5779 T5781 det the,tissues
R3989 T5780 T5781 compound tumor,tissues
R3990 T5781 T5778 pobj tissues,in
R3991 T5782 T5781 prep of,tissues
R3992 T5783 T5787 nummod CCR5,mice
R3993 T5784 T5787 nummod −,mice
R3994 T5785 T5787 nmod /,mice
R3995 T5786 T5787 compound −,mice
R3996 T5787 T5782 pobj mice,of
R3997 T5788 T5789 punct (,Figure
R3998 T5789 T5781 appos Figure,tissues
R3999 T5790 T5789 npadvmod 2C,Figure
R4000 T5791 T5789 punct ),Figure
R4001 T5792 T5767 punct .,confirmed

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T5858 714-723 Negative_regulation denotes decreased
T5857 685-692 Entity denotes nuclear
T5856 706-709 Protein denotes p50
T5855 560-569 Negative_regulation denotes prevented
T5854 560-569 Negative_regulation denotes prevented
T5853 514-524 Negative_regulation denotes inhibition
T5852 514-524 Negative_regulation denotes inhibition
T5851 514-524 Negative_regulation denotes inhibition
T5850 454-467 Localization denotes translocation
T5849 454-467 Localization denotes translocation
T5848 528-543 Phosphorylation denotes phosphorylation
T5847 494-501 Entity denotes nucleus
T5846 547-550 Protein denotes IκB
T5845 479-484 Protein denotes p-p65
T5844 471-474 Protein denotes p50
T5843 233-240 Binding denotes binding
T5842 190-202 Negative_regulation denotes inactivation
T5841 253-258 Protein denotes NF-κB
T5840 206-211 Protein denotes NF-κB
T5839 116-126 Gene_expression denotes expression
T5838 4-14 Positive_regulation denotes activation
T5837 111-115 Protein denotes CCR5
T5836 18-23 Protein denotes NF-κB
R4019 T5836 T5838 themeOf NF-κB,activation
R4020 T5837 T5839 themeOf CCR5,expression
R4021 T5840 T5842 themeOf NF-κB,inactivation
R4022 T5841 T5843 themeOf NF-κB,binding
R4023 T5844 T5849 themeOf p50,translocation
R4024 T5845 T5850 themeOf p-p65,translocation
R4025 T5846 T5848 themeOf IκB,phosphorylation
R4026 T5847 T5849 locationOf nucleus,translocation
R4027 T5847 T5850 locationOf nucleus,translocation
R4028 T5848 T5853 themeOf phosphorylation,inhibition
R4029 T5849 T5851 themeOf translocation,inhibition
R4030 T5849 T5854 themeOf translocation,prevented
R4031 T5850 T5852 themeOf translocation,inhibition
R4032 T5850 T5855 themeOf translocation,prevented
R4033 T5856 T5858 themeOf p50,decreased